Rockefeller Capital Management’s Axsome Therapeutics AXSM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-350
| Closed | -$27K | – | 2127 |
|
|
2022
Q4 | $27K | Hold |
350
| – | – | ﹤0.01% | 2675 |
|
|
2022
Q3 | $15K | Hold |
350
| – | – | ﹤0.01% | 2890 |
|
|
2022
Q2 | $13K | Hold |
350
| – | – | ﹤0.01% | 2973 |
|
|
2022
Q1 | $14K | Hold |
350
| – | – | ﹤0.01% | 2876 |
|
|
2021
Q4 | $13K | Hold |
350
| – | – | ﹤0.01% | 2831 |
|
|
2021
Q3 | $11K | Hold |
350
| – | – | ﹤0.01% | 2833 |
|
|
2021
Q2 | $23K | Hold |
350
| – | – | ﹤0.01% | 2418 |
|
|
2021
Q1 | $19K | Hold |
350
| – | – | ﹤0.01% | 2295 |
|
|
2020
Q4 | $28K | Sell |
350
-2,000
| -85% | -$160K | ﹤0.01% | 1872 |
|
|
2020
Q3 | $167K | Hold |
2,350
| – | – | ﹤0.01% | 1101 |
|
|
2020
Q2 | $193K | Hold |
2,350
| – | – | ﹤0.01% | 960 |
|
|
2020
Q1 | $138K | Buy |
+2,350
| New | +$138K | ﹤0.01% | 917 |
|